Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03394885
Title Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer (AdORN)
Acronym AdORN
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Duke University
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.